Pillar Clinical Research

Bentonville, Arkansas 72712

5 studies enrolling now · 16 studies all time

What they study most

Bipolar I Disorder, Borderline Personality Disorder, Depression, Postpartum, Electronic Cigarette Use, Epilepsy, Focal Epilepsy, Focal Seizure, Major Depressive Disorder, Methamphetamine Abuse, Methamphetamine-dependence, Post-Natal Depression, Post-partum Depression

Studies at this site

• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) — Recruiting now
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. — Recruiting now
• 52-week Open Label Safety-Tolerability Study — Recruiting now
• Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia — Recruiting now
• A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression — Completed
• Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products — Completed
• A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder — Completed
• Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia — Completed
• A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) — Completed
• An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) — Completed
• Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 — Stopped early
• A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia — Stopped early
• Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System — Completed
• A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia — Completed